Class information for:
Level 1: ACUTE LYMPHOBLASTIC LEUKEMIA//MINIMAL RESIDUAL DISEASE//ACUTE LYMPHOBLASTIC LEUKAEMIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
906 2885 36.1 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
81 26583 MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACUTE LYMPHOBLASTIC LEUKEMIA Author keyword 126 19% 21% 593
2 MINIMAL RESIDUAL DISEASE Author keyword 56 20% 9% 252
3 ACUTE LYMPHOBLASTIC LEUKAEMIA Author keyword 28 21% 4% 117
4 ADULT ALL Author keyword 24 63% 1% 24
5 ADULT ACUTE LYMPHOBLASTIC LEUKEMIA Author keyword 22 67% 1% 20
6 ALL Author keyword 22 15% 5% 134
7 PHILADELPHIA CHROMOSOME Author keyword 20 21% 3% 86
8 MRD Author keyword 16 27% 2% 52
9 PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA Author keyword 13 61% 0% 14
10 MINIMAL RESIDUAL DISEASE MRD Author keyword 12 35% 1% 28

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ACUTE LYMPHOBLASTIC LEUKEMIA 126 19% 21% 593 Search ACUTE+LYMPHOBLASTIC+LEUKEMIA Search ACUTE+LYMPHOBLASTIC+LEUKEMIA
2 MINIMAL RESIDUAL DISEASE 56 20% 9% 252 Search MINIMAL+RESIDUAL+DISEASE Search MINIMAL+RESIDUAL+DISEASE
3 ACUTE LYMPHOBLASTIC LEUKAEMIA 28 21% 4% 117 Search ACUTE+LYMPHOBLASTIC+LEUKAEMIA Search ACUTE+LYMPHOBLASTIC+LEUKAEMIA
4 ADULT ALL 24 63% 1% 24 Search ADULT+ALL Search ADULT+ALL
5 ADULT ACUTE LYMPHOBLASTIC LEUKEMIA 22 67% 1% 20 Search ADULT+ACUTE+LYMPHOBLASTIC+LEUKEMIA Search ADULT+ACUTE+LYMPHOBLASTIC+LEUKEMIA
6 ALL 22 15% 5% 134 Search ALL Search ALL
7 PHILADELPHIA CHROMOSOME 20 21% 3% 86 Search PHILADELPHIA+CHROMOSOME Search PHILADELPHIA+CHROMOSOME
8 MRD 16 27% 2% 52 Search MRD Search MRD
9 PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA 13 61% 0% 14 Search PHILADELPHIA+CHROMOSOME+POSITIVE+ACUTE+LYMPHOBLASTIC+LEUKEMIA Search PHILADELPHIA+CHROMOSOME+POSITIVE+ACUTE+LYMPHOBLASTIC+LEUKEMIA
10 MINIMAL RESIDUAL DISEASE MRD 12 35% 1% 28 Search MINIMAL+RESIDUAL+DISEASE+MRD Search MINIMAL+RESIDUAL+DISEASE+MRD

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACUTE LYMPHOCYTIC LEUKEMIA 149 26% 17% 488
2 2ND REMISSION 143 67% 5% 130
3 PRECURSOR B ALL 69 73% 2% 52
4 LALA 94 TRIAL 62 92% 1% 24
5 HYPER CVAD 58 48% 3% 89
6 INTERMEDIATE DOSE METHOTREXATE 58 92% 1% 23
7 UNFAVORABLE PRESENTING FEATURES 58 83% 1% 33
8 STANDARD RISK 57 63% 2% 57
9 MINIMAL RESIDUAL DISEASE 51 12% 14% 407
10 INTENSIVE CONSOLIDATION 46 82% 1% 27

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Drug therapy - Treatment of acute lymphoblastic leukemia 2006 818 99 41%
Modern Therapy of Acute Lymphoblastic Leukemia 2011 90 66 77%
Acute lymphoblastic leukaemia 2008 501 161 35%
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008 2010 92 81 80%
Relapsed childhood acute lymphoblastic leukaemia 2013 38 76 42%
Acute lymphoblastic leukemia 1998 512 99 46%
Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia 2015 4 67 36%
Current status of antibody therapy in ALL 2015 3 56 45%
Acute Lymphoblastic Leukemia: Monitoring Minimal Residual Disease as a Therapeutic Principle 2012 25 85 88%
Minimal residual disease monitoring in childhood acute lymphoblastic leukemia 2012 19 56 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MIDWEST CANC BLOOD DISORDERS 6 50% 0.3% 8
2 TREATMENT HEMATONOSIS 4 75% 0.1% 3
3 PEDIAT HEMATOL CHEMOTHER Y 4 40% 0.3% 8
4 ADULT BMT UNIT 3 35% 0.3% 8
5 TETTAMANTI 3 35% 0.2% 7
6 UNIV BERLIN 3 60% 0.1% 3
7 PEDIAT ONCOL GRP STAT OFF 2 28% 0.2% 7
8 UNIV ROTTERDAM HOSP 2 17% 0.4% 12
9 RIC M TETTAMANTI 2 20% 0.3% 10
10 ONCOL DAY BEDS 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000208640 TEL AML1//LEUKAEMIA CYTOGENET GRP//ETV6
2 0.0000140820 HEMATOGONES//BIPHENOTYPIC ACUTE LEUKEMIA//IMMUNOPHENOTYPING
3 0.0000131300 CLOFARABINE//CANC THER EUT IMMUNOL//NELARABINE
4 0.0000116196 INT OUTREACH PROGRAM//DUTCH CANC//DOCTOR DOCTOR PROGRAM 2
5 0.0000080721 L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE
6 0.0000077831 COGNITIVE LATE EFFECTS//INTRATHECAL METHOTREXATE//SOMNOLENCE SYNDROME
7 0.0000076845 AGE DEPENDENT DISEASES//MCKNIGHT BRAIN NEUROSCI//CLINICAL EXAMINATIONS
8 0.0000075099 BIOMED 2//TREPHINE BIOPSY//BONE MARROW BIOPSY
9 0.0000067485 LYMPHOBLASTIC LYMPHOMA//BURKITTS LYMPHOMA//BURKITT LYMPHOMA
10 0.0000065100 ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML